Genomics-driven oncology: framework for an emerging paradigm.

Abstract excerpt

A majority of cancers are driven by genomic alterations that dysregulate key oncogenic pathways influencing cell growth and survival. However, the ability to harness tumor genetic information for its full clinical potential has only recently become manifest. Over the past several years, the convergence of discovery, technology, and therapeutic development has created an unparalleled opportunity to test the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Neoplasms
• Share to Chromosome Aberrations
• Share to Gene Regulatory Networks